Company Overview
Research, development, commercialisation of proprietory technologies and global distribution of HVAC/R Hygiene, anti-corrosion and disinfectant products; provision of HVAC/R Hygiene and Remediation technology, indoor air quality and corrosion protection services.
| Website | www.aerisenvironmental.com |
|---|---|
| Head Office | Rosebery NSW |
| Registry | Computershare Investor Service |
| CEO | Andrew Just |
| Chair Person | Maurie Stang |
| GICS Industry | Commercial & Professional Services |
| Sub Industry | Environmental & Facilities Services |
| Sector | Industrials |
| Market Cap | $14 m |
|---|---|
| Shares on Issue | 244 m |
| Status | Trading |
| Last Price | |
| Change | |
| 52 Week H/L | |
| VWAP | |
| Bid/Ask |
Directors and Management
Mr Maurie Stang
Non-Executive Chairman,Non-Executive Director 24/07/2002
Mr Stang is a director of the Regional Health Care Group of companies and of Novapharm Research. He has over 30 years of experience building and managing companies in the Australian healthcare market, and networks within the life-sciences and pharmaceutical sectors, both in Australia and internationally. Since co-founding the Regional Health Care Group. He is Member of Risk Committee and Chairman of Corporate Governance Committee.
Male
Mr Steven Kritzler
Non-Executive Director 11/02/2005
Mr Kritzler holds a number of international patents. He is the Technical Director of Novapharm Research. Mr Kritzler has over 40 years of experience in commercial R&D in the areas of pharmaceutical, medical, cosmetic and specialty industrial products.
MSc (Polymer Chemistry) Male
Dr Jenny Lee Harry
Non-Executive Director 21/04/2021
Dr Harry has 20 years' experience in executive management of companies in the biotechnology, diagnostic and biopharmaceutical sectors. Jenny is a CEO with experience in growing companies from start-up to commercialisation, establishing global partnerships, capital raising, investor relations, together with corporate governance and compliance. She is an experienced Non-Executive Director on the Boards of listed and unlisted companies. Dr Harry is currently a Non-Executive Director of Neuren Pharmaceuticals Limited (ASX:NEU) and Ondek Pty Ltd, and a member of the Board's IP sub-Committee of the Children's Medical Research Institute.
BSc(Hons), DipEd, PhD, GMP(Harvard ), GAICD Female
Mr Peter Bush
Chief Financial Officer,Alternate Director Maurie Stang,Chief Executive Officer,Executive Director 30/06/2011
Mr Bush is the Chief Financial Officer of the Regional Health Care Group of companies and of GryphonCapital. He began his career working for five years at BDO and has since spent a number of years working in industry. Mr Bush holds a number of private directorships and board positions.
BCom, GradDipCA, MICA Male
Mr Michael Ford
Non-Executive Director 23/04/2020
Mr Ford has over 30 years of experience in Finance and Strategy roles in a range of industries including manufacturing, property and financial services. Michael is the Chief Financial Officer of News Corp Australia and a Director of Foxtel. He is a former Group CFO of QBE Insurance and Deputy CFO of Commonwealth Bank of Australia. Michael is an experienced Company Director.
AMP,BCom,MBA,FCA,FCPA,GAICD Male
Dr Abbie Widin
Non-Executive Director 02/03/2021
Dr Widin has over 20 years' experience in the global consumer goods and consulting markets. She has held various marketing, commercial and management roles in both private and public companies, such as Procter & Gamble (Australia and Europe), SC Johnson, Reckitt Benckiser and Kellogg.
PhD (Physiology),BMedSc(Hons),DipBusAdmin Female
Top 20 Shareholders
| Name | Shares | % | |
|---|---|---|---|
| 1. | Not disclosed in Annual Report | 0 | 0.00 |
Director Transactions
| Date | Name | Qty | Value | Direction | Notes |
|---|